Company profile · Kaunas, Lithuania

Biomapas

Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information · Pan-European clinical-services network

Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.

Lead
Xavier Duburcq (verified ↗)
Address
K. Donelaičio g. 60, LT-44248 Kaunas, Lithuania (source ↗)
Compliance
GxP-aligned pharma services platform
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Pan-European clinical-services network
Capabilities
Clinical Trial Management · Pharmacovigilance · Regulatory Affairs
Founded
2007
Headcount
201-500
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Xavier Duburcq

Chief Executive Officer

Check official leadership source
Full addressK. Donelaičio g. 60, LT-44248 Kaunas, Lithuania
Site coordinates54.899456, 23.915108
Review cycleMay 2026
Physical site source

Official Biomapas contact page listing the Kaunas headquarters address.

Open source
Operating profile

Pan-European clinical-services network

Kaunas, Lithuania. Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information. Review completed on 14 Mar 2026.

2026 technical specializationClinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information
Core capabilities
Clinical Trial ManagementPharmacovigilanceRegulatory AffairsMedical Information
Governance

EU clinical, pharmacovigilance, and regulatory-services oversight

GxP-aligned pharma services platform, Clinical and pharmacovigilance operating controls

Editorial note

Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information

Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.

Editorial note

Biomapas is published as a Lithuanian clinical-services connector with a fresh February 25, 2026 CEO appointment and a pan-European service model.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Clinical Trial Management
Pharmacovigilance
Regulatory Affairs
Medical Information
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBiomapas official February 2026 CEO appointment release.Source origin: biomapas.comOpen source
Supporting evidenceBiomapas official company surface describing the integrated pharma-services platform.Source origin: biomapas.comOpen source
Physical-site evidenceOfficial Biomapas contact page listing the Kaunas headquarters address.Source origin: biomapas.comOpen source
Infrastructure

Declared infrastructure

Clinical operations systems
Pharmacovigilance workflows
Regulatory documentation platform
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Biomapas located?
Biomapas operates from K. Donelaičio g. 60, LT-44248 Kaunas, Lithuania, Kaunas, Lithuania.
Who runs Biomapas?
Biomapas is led by Xavier Duburcq, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Biomapas hold?
Biomapas is documented under GxP-aligned pharma services platform.
What does Biomapas do?
Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways. Core capabilities: Clinical Trial Management, Pharmacovigilance, Regulatory Affairs, Medical Information.
Editorial context

Related technical briefs

Briefs that name Kaunas as a covered market or city.